Just a few years ago, the idea of artificial intelligence (AI) designing new virus variants seemed like science fiction. However, recent research has proven otherwise. In a groundbreaking study, AI developed new virus variants within minutes -- a feat even the world’s most advanced laboratories would find challenging.
Scientists selected 72 proteins linked to dangerous viruses and toxins for this research. Using AI tools, thousands of new variants of these proteins were generated. These variants were then tested through a Biosecurity Screening System (BSS), a technology used by DNA synthesis companies to screen every order for potential risks.
Initially, many harmful variants bypassed the screening system, raising serious concerns. However, after upgrading the system, about 97% of the dangerous variants are now successfully detected and blocked.
While this breakthrough opens up promising avenues for accelerated drug development against severe diseases, it also highlights a critical risk: if this technology falls into the wrong hands, it could potentially fuel biological threats and terrorism.
The dual nature of AI in biotechnology calls for strict regulation and vigilant monitoring to harness its benefits while minimizing risks.
No comments yet. Be the first to comment!